Status:
COMPLETED
Pseudodrynaria Coronana (Wall) Ching
Lead Sponsor:
National Taiwan University Hospital
Collaborating Sponsors:
Sheng Chang Pharmaceutical
Conditions:
Osteoporosis
Eligibility:
FEMALE
45-70 years
Phase:
PHASE1
Brief Summary
The Study to evaluate the clinical effect of "Gusuibu" lasts for 3 years. It aims to evaluate its effect on bone density of postmenopausal osteoporosis. Besides, its effects on the liver, kidney and t...
Detailed Description
Research of the this traditional chinese medicine clinucal, Gusuibu, curative effect is plan three years time. The entire studyaims to evaluated the effect of the traditional chinese medicine on postm...
Eligibility Criteria
Inclusion
- postmenopausal osteoporosis
Exclusion
- Insulin dependent diabetes
Key Trial Info
Start Date :
January 1 2000
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2001
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00155675
Start Date
January 1 2000
End Date
January 1 2001
Last Update
January 12 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Medical Center
Taipei, 7, Chung-Shan S. Road, Taiwan, 100